Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,202 JPY | +0.69% | +1.64% | +3.65% |
Sales 2024 | 4,264B 27.17B | Sales 2025 * | 4,230B 26.96B | Capitalization | 6,547B 41.72B |
---|---|---|---|---|---|
Net income 2024 | 144B 918M | Net income 2025 * | 114B 727M | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.03B | Net Debt 2025 * | 3,993B 25.44B | EV / Sales 2025 * | 2.49 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
60.6
x | Employees | 49,095 |
Yield 2024 |
4.49% | Yield 2025 * |
4.63% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +0.69% | ||
1 week | +1.72% | ||
Current month | +0.69% | ||
1 month | +2.51% | ||
3 months | -3.84% | ||
6 months | +1.69% | ||
Current year | +3.65% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 19 M€ | +11.04% | ||
5.00% | 288 M€ | +29.31% | ||
3.80% | 1,531 M€ | +27.08% | ||
3.43% | 240 M€ | +19.29% | ||
3.26% | 60 M€ | +25.35% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 4,202 | +0.69% | 4 707 300 |
24-05-31 | 4,173 | +1.88% | 8,890,100 |
24-05-30 | 4,096 | -0.41% | 4,054,100 |
24-05-29 | 4,113 | -0.92% | 2,662,200 |
24-05-28 | 4,151 | +0.48% | 2,142,300 |
Delayed Quote Japan Exchange, June 03, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.65% | 41.64B | |
+40.73% | 739B | |
+31.57% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.25% | 240B | |
+9.53% | 210B | |
-5.11% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 4502 Stock